R&s (RSGN.SW) traded up 6.44 % during a 24 hours period ending at 07:15 AM Central Europe on Friday 30th. One R&s stock can currently be bought for about CHF 19.19 on popular exchanges. Current supply of R&s stocks is 37.2 mn. R&s has a current market capitalization of CHF 804 mn and approximately CHF 3.9 mn worth of R&s was traded on exchanges in the last 24 hours. Since last month end, R&s has traded 6.44 % up. Simple moving average of last 200 days is at CHF 21.53. The highest price of past 52 weeks was recorded at CHF 29.42 on 05/07/2026. 52 weeks low was at CHF 14.7 on 01/14/2026.
Here is how related stocks have performed in the past 24 hours:
Vaudoise Assurances Hol (VAHN.SW) traded up 0.14 % and now trades at CHF 741. Vaudoise Assurances Hol has a market capitalisation of CHF 740 mn. Current price/earnings ratio for Vaudoise Assurances Hol is 13.89.
Thurgauer Kantonalbank (TKBP.SW) traded up 0.31 % and now trades at CHF 161. Thurgauer Kantonalbank has a market capitalisation of CHF 720.7 mn. Thurgauer Kantonalbank has a current price to earnings ratio of 3.96.
Moonlake Immunotherapeutics (MLTX) traded up 3.19 % and now trades at USD 12.57. Moonlake Immunotherapeutics has a market capitalisation of USD 1.1 bn.
Autoneum (AUTN.SW) traded up 0.17 % and now trades at CHF 119.8. Current market capitalisation for Autoneum is CHF 775.9 mn. Current price/earnings ratio for Autoneum is 11.34.
Kuros Biosciences (KURN.SW) traded up 5.23 % and now trades at CHF 20.84. Kuros Biosciences has a market capitalisation of CHF 927.6 mn. Current price/earnings ratio for Kuros Biosciences is 108.48.
About R&s
The R&S Group Holding AG is a holding company that serves customers worldwide. Through its subsidiaries, the company manufactures small and medium power and distribution transformers, as well as other components in the utility, infrastructure, and industrial sectors.